Janux Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.About JANX
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
JANX Key Statistics
Stock Snapshot
As of today, Janux Therapeutics(JANX) shares are valued at $13.97. The company's market cap stands at 849.82M, with a P/E ratio of -7.83.
During the trading session on 2026-03-05, Janux Therapeutics(JANX) shares reached a daily high of $14.24 and a low of $13.66. At a current price of $13.97, the stock is +2.3% higher than the low and still -1.9% under the high.
Trading volume for Janux Therapeutics(JANX) stock has reached 1.05M, versus its average volume of 807.04K.
The stock's 52-week range extends from a low of $12.12 to a high of $35.34.
The stock's 52-week range extends from a low of $12.12 to a high of $35.34.
Analyst ratings
89%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.